Journal ArticleDOI
Interstitial lung disease in systemic sclerosis: a simple staging system.
Nicole S. L. Goh,Sujal R. Desai,Srihari Veeraraghavan,David M. Hansell,Susan J. Copley,Toby M. Maher,Tamera J. Corte,Clare R. Sander,Jonathan Ratoff,Anand Devaraj,Gracijela Bozovic,Christopher P. Denton,Carol M. Black,Roland M. du Bois,Athol U. Wells +14 more
Reads0
Chats0
TLDR
An easily applicable limited/extensive staging system for SSc-ILD, based on combined evaluation with HRCT and PFTs, provides discriminatory prognostic information.Abstract:
Rationale: In interstitial lung disease complicating systemic sclerosis (SSc-ILD), the optimal prognostic use of baseline pulmonary function tests (PFTs) and high-resolution computed tomography (HRCT) is uncertain.Objectives: To construct a readily applicable prognostic algorithm in SSc-ILD, integrating PFTs and HRCT.Methods: The prognostic value of baseline PFT and HRCT variables was quantified in patients with SSc-ILD (n = 215) against survival and serial PFT data.Measurements and Main Results: Increasingly extensive disease on HRCT was a powerful predictor of mortality (P < 0.0005), with an optimal extent threshold of 20%. In patients with HRCT extent of 10–30% (termed indeterminate disease), an FVC threshold of 70% was an adequate prognostic substitute. On the basis of these observations, SSc-ILD was staged as limited disease (minimal disease on HRCT or, in indeterminate cases, FVC ⩾ 70%) or extensive disease (severe disease on HRCT or, in indeterminate cases, FVC < 70%). This system (hazards ratio [H...read more
Citations
More filters
Journal ArticleDOI
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
TL;DR: The adverse-event profile of nintedanib observed in this trial was similar to that observed in patients with idiopathic pulmonary fibrosis; gastrointestinal adverse events, including diarrhea, were more common with nintinganib than with placebo.
Journal ArticleDOI
Prediction of pulmonary complications and long-term survival in systemic sclerosis.
Svetlana I. Nihtyanova,Benjamin E. Schreiber,Voon H Ong,Daniel W. Rosenberg,Pia Moinzadeh,J. Gerrard Coghlan,Athol U. Wells,Christopher P. Denton +7 more
TL;DR: To assess survival and incidence of organ‐based complications in a large single‐center cohort of unselected systemic sclerosis patients, and to explore predictors of survival and clinically significant pulmonary fibrosis and pulmonary hypertension.
Journal ArticleDOI
Mortality in bronchiectasis: a long-term study assessing the factors influencing survival
Michael R. Loebinger,Athol Wells,David M. Hansell,N Chinyanganya,Anand Devaraj,Mark G. Meister,Robert Wilson +6 more
TL;DR: In patients with moderate to severe bronchiectasis, mortality is associated with a degree of restrictive and obstructive disease, poor gas transfer and chronic pseudomonas infection, which should guide future research into disease progression, and identify those patients needing intensive treatment.
Journal ArticleDOI
Interstitial lung disease in connective tissue disorders.
Aryeh Fischer,Roland M. du Bois +1 more
TL;DR: In this focused review, aspects of prognosis for CTD-ILD and what indices might predict outcome are addressed, together with lessons that can be learnt from clinical trials of systemic sclerosis-associated ILD and idiopathic pulmonary fibrosis and how these lessons might be applied to future studies of CTd-ILD.
Journal ArticleDOI
Diagnosis and treatment of connective tissue disease-associated interstitial lung disease
Rekha Vij,Mary E. Strek +1 more
TL;DR: New information is presented regarding the diagnosis and treatment of patients with ILD secondary to systemic sclerosis, rheumatoid arthritis, dermatomyositis and polymyositis, and Sjögren syndrome and diagnostic criteria for CTD are presented.
References
More filters
Journal Article
Understanding interobserver agreement: the kappa statistic.
TL;DR: Items such as physical exam findings, radiographic interpretations, or other diagnostic tests often rely on some degree of subjective interpretation by observers and studies that measure the agreement between two or more observers should include a statistic that takes into account the fact that observers will sometimes agree or disagree simply by chance.
Journal ArticleDOI
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
TL;DR: A multicenter, ongoing study of early-diagnosed cases of systemic sclerosis and comparison patients with systemic lupus erythematosus, polymyositis/dermatomyositis, and Raynaud's phenomenon was conducted in order to develop classification criteria for systemic sclerosis.
Journal ArticleDOI
Cyclophosphamide versus placebo in scleroderma lung disease.
Donald P. Tashkin,Robert Elashoff,Philip J. Clements,Jonathan G. Goldin,Michael D. Roth,Daniel E. Furst,Edgar Arriola,Richard M. Silver,Charlie Strange,Marcy B. Bolster,James R. Seibold,David J. Riley,Vivien Hsu,John Varga,Dean E. Schraufnagel,Arthur C. Theodore,Robert W. Simms,Robert A. Wise,Fredrick M. Wigley,Barbara White,Virginia D. Steen,Charles A. Read,Maureen D. Mayes,Ed Parsley,Kamal K. Mubarak,M. Kari Connolly,Jeffrey A. Golden,Mitchell A. Olman,B. J. Fessler,Naomi F. Rothfield,Mark L. Metersky +30 more
TL;DR: One year of oral cyclophosphamide in patients with symptomatic scleroderma-related interstitial lung disease had a significant but modest beneficial effect on lung function, dyspnea, thickening of the skin, and the health-related quality of life.
Journal ArticleDOI
Survival model predictive accuracy and ROC curves.
Patrick J. Heagerty,Yingye Zheng +1 more
TL;DR: New time-dependent accuracy summaries based on time-specific versions of sensitivity and specificity calculated over risk sets are proposed based on a previously proposed global concordance measure, which is a variant of Kendall's tau.
Journal ArticleDOI
Severe organ involvement in systemic sclerosis with diffuse scleroderma.
TL;DR: It is demonstrated that severe organ involvement in SSc patients with diffuse scleroderma most often occurs early in the course of the disease.
Related Papers (5)
Cyclophosphamide versus placebo in scleroderma lung disease.
Donald P. Tashkin,Robert Elashoff,Philip J. Clements,Jonathan G. Goldin,Michael D. Roth,Daniel E. Furst,Edgar Arriola,Richard M. Silver,Charlie Strange,Marcy B. Bolster,James R. Seibold,David J. Riley,Vivien Hsu,John Varga,Dean E. Schraufnagel,Arthur C. Theodore,Robert W. Simms,Robert A. Wise,Fredrick M. Wigley,Barbara White,Virginia D. Steen,Charles A. Read,Maureen D. Mayes,Ed Parsley,Kamal K. Mubarak,M. Kari Connolly,Jeffrey A. Golden,Mitchell A. Olman,B. J. Fessler,Naomi F. Rothfield,Mark L. Metersky +30 more
Changes in causes of death in systemic sclerosis, 1972-2002.
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
A Tyndall,Bettina Bannert,Madelon C. Vonk,Paolo Airò,Franco Cozzi,Patricia Carreira,Dominique Farge Bancel,Yannick Allanore,Ulf Müller-Ladner,Oliver Distler,Florenzo Iannone,Raffaele Pellerito,Margarita Pileckyte,I. Miniati,L. Ananieva,Alexandra Balbir Gurman,Nemanja Damjanov,Adelheid Mueller,Gabriele Valentini,Gabriela Riemekasten,Mohammed Tikly,Laura K. Hummers,Maria João Henriques,Paola Caramaschi,Agneta Scheja,Blaz Rozman,Evelien Ton,Gábor Kumánovics,Bernard Coleiro,Eva Feierl,Gabriella Szücs,Carlos Alberto Von Mühlen,Valeria Riccieri,Srdan Novak,Carlo Chizzolini,Anna Kotulska,Christopher P. Denton,Paulo C. Coelho,Ina Kötter,Ismail Simsek,Paloma García de la Peña Lefebvre,Eric Hachulla,James R. Seibold,Simona Rednic,Jiri Stork,Jadranka Morović-Vergles,Ulrich A. Walker +46 more
2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative
Frank H J van den Hoogen,Dinesh Khanna,Jaap Fransen,Sindhu R Johnson,Murray Baron,Alan Tyndall,Marco Matucci-Cerinic,Raymond P. Naden,Thomas A. Medsger,Patricia Carreira,Gabriela Riemekasten,Philip J. Clements,Christopher P. Denton,Oliver Distler,Yannick Allanore,Daniel E. Furst,Armando Gabrielli,Maureen D. Mayes,Jacob M van Laar,James R. Seibold,László Czirják,Virginia D. Steen,Murat Inanc,Otylia Kowal-Bielecka,Ulf Müller-Ladner,Gabriele Valentini,Douglas J. Veale,Madelon C. Vonk,Ulrich A Walker,Lorinda Chung,David H. Collier,David H. Collier,Mary Ellen Csuka,Barri J. Fessler,Serena Guiducci,Ariane L. Herrick,Vivien Hsu,Sergio A. Jimenez,Bashar Kahaleh,Bashar Kahaleh,Peter A. Merkel,Stanislav Sierakowski,Richard M. Silver,Robert W. Simms,Robert W. Simms,John Varga,Janet E. Pope +46 more